Loading
Our Oral Solid Dosage Formulation Services provide end-to-end development support for tablets, capsules, and
oral films across multiple therapeutic segments.
We apply an integrated formulation approach to support efficient progression from early development through clinical
and commercial readiness.


Oral solid dosage forms remain one of the most widely utilized pharmaceutical product categories due to their convenience, dosing accuracy, and manufacturing flexibility.
Our formulation development approach integrates pre-formulation data, biopharmaceutics, process development, and analytical support to enable robust and scalable oral solid dosage products.
We support a wide range of product designs, including immediate-release, modified-release, and patient-centric oral solid forms.
We provide comprehensive formulation development support for Phase I, II, and III clinical trials involving new chemical entities.
Oral solid formulations are designed to meet performance, manufacturability, and regulatory requirements that support smooth clinical progression.
Development of immediate-release, controlled-release, and modified-release tablets guided by biopharmaceutics, excipient selection, and manufacturability.
Development of hard gelatin and HPMC capsules, including powder-filled, pellet-based, and liquid-filled systems designed for consistent performance.
Development of fast-dissolving and buccal oral films focused on patient convenience, dose accuracy, uniform drug distribution, and formulation stability
We support the development of differentiated generic and over-the-counter oral solid dosage products through structured formulation and process development activities.
Our approach focuses on creating formulations that enhance performance, patient compliance, and lifecycle value.

Oral solid formulation development activities are conducted within structured quality systems to ensure data integrity, traceability, and alignment with regulatory expectations.
Oral solid dosage forms offer flexibility, patient convenience, and compatibility with large-scale manufacturing.
Let’s discuss how our pharmaceutical capabilities can support your requirements.